Skip to main content

Therapeutics Startups

Updated November 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,733
Total Funding
$1.7B
Avg Funding
$66.7M
Global Reach
8
countries

Top Cities for Therapeutics

Boston
Cantanhede
New York
South San Francisco
Iselin
Wilmington

Recently Funded Companies

Export
Boston, United States

Endlyz Therapeutics is developing disease-modifying therapeutics for Parkinson’s disease (PD) and other dementias.

$17.3M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Cantanhede, Portugal

Exogenus Therapeutics develops cellular based therapies applied to regenerative medicine for skin lesions treatment.

Apr 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.

$18.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

$150.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Iselin, United States

Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.

$5.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Wilmington, United States

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

$90.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

$125.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Brisbane, United States

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Apr 2026

Founder Contacts

41,000+ verified contacts

Regensburg, Germany

Brainjo uses virtual reality (VR) and brain-computer interfaces for treating ADHD, providing a modern approach to mental health care.

$2.4M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Canton, United States

Orthogon Therapeutics is a drug development company developing antiviral drugs for immune-suppressed patients.

$11.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Basel, Switzerland

Allegria Therapeutics is a biotech firm that engages in the research and treatment of allergy and mast cell-mediated inflammatory diseases.

$1.5M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Seattle, United States

Bonum Therapeutics creates a technology platform to treat a wide range of diseases.

$26.9M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

New York, United States

MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.

$100.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Eindhoven, The Netherlands

Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.

$47.8M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

White Plains, United States

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

$7.1M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Storm Therapeutics develops small-molecule therapies that target RNA-modifying enzymes to treat cancer and other diseases.

$56.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Verismo Therapeutics is a biotechnology company that develops CAR T cell therapy for the treatment of solid tumors.

$28.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Waltham, United States

Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.

$40.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.

$300.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Tokyo, Japan

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

$8.2M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Sunrise, United States

Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.

$403.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

$75.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Cleveland, United States

Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.

$700K raised
Apr 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.

$100.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Woburn, United States

Vivatides Therapeutics develops RNA treatments to help improve patients' lives using biotechnology research.

$54.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Showing 251 to 275 of 1,733 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.

Average Funding
$66.7M
Total Funding Tracked
$1.7B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.Boston
2 companies$317.3M
2.New York
2 companies$118.0M
3.San Diego
2 companies$225.0M
4.Cantanhede
1 companiesUndisclosed
5.South San Francisco
1 companies$150.0M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

1,733 Therapeutics Startups (2026) — Recently Funded — Page 11 | VCBacked